Andrew Zloza
- Oncology top 2%
- Genetics top 1%
- Immunology top 2%
- Molecular Biology top 10%
- Infectious Diseases top 5%
- Co-authors
- Howard L. KaufmanFrederick J. KohlhappPraveen K. BommareddyDavid M. AboulafiaP RubinsteinSamuel D. RabkinJason M. SchenkelErica Huelsmann
- Topics
- Immunotherapy and Immune Responses (23 papers)CAR-T cell therapy research (22 papers)Virus-based gene therapy research (19 papers)
- Cited by
- ImmunologyOncologyGenetics
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
Andrew Zloza
78 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 1.6k
- Genetics 1.3k
- Immunology 1.3k
- Molecular Biology 1.1k
- Infectious Diseases 343
Countries citing papers authored by Andrew Zloza
This map shows the geographic impact of Andrew Zloza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Zloza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Zloza more than expected).
Fields of papers citing papers by Andrew Zloza
This network shows the impact of papers produced by Andrew Zloza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Zloza. The network helps show where Andrew Zloza may publish in the future.
Co-authorship network of co-authors of Andrew Zloza
This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Zloza. A scholar is included among the top collaborators of Andrew Zloza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Zloza. Andrew Zloza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 3 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 8 | |
| 7 | 9 | |
| 8 | 97 | |
| 9 | ONC201 IN COMBINATION WITH RADIATION EXHIBITS SYNERGISTIC EFFICACY IN HIGH GRADE GLIOMAS AND OTHER ADVANCED CANCERS | 1 |
| 10 | 30 | |
| 11 | 14 | |
| 12 | 130 | |
| 13 | 101 | |
| 14 | 3 | |
| 15 | 7 | |
| 16 | 6 | |
| 17 | 19 | |
| 18 | 70 | |
| 19 | 1 | |
| 20 | 13 |
About Andrew Zloza
Andrew Zloza is a scholar working on Immunology, Oncology and Biotechnology, having authored 83 papers that have together received 3.4k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (23 papers), CAR-T cell therapy research (22 papers) and Virus-based gene therapy research (19 papers). The work is most often cited by research in Immunology (1.3k citations), Oncology (1.6k citations) and Genetics (1.3k citations). Andrew Zloza has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Howard L. Kaufman, Frederick J. Kohlhapp, Praveen K. Bommareddy, David M. Aboulafia, P Rubinstein, Samuel D. Rabkin, Jason M. Schenkel, Erica Huelsmann, Charles B. Chesson and Lena Al‐Harthi. Their work appears in journals such as Journal of Clinical Investigation, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.